Effects of ketamine on different types of anxiety/fear and related memory in rats with lesions of the median raphe nucleus

被引:32
作者
Babar, E [1 ]
Özgünen, T
Melik, E
Polat, S
Akman, H
机构
[1] Cukurova Univ, Fac Med, Dept Physiol, Div Neurophysiol, TR-01330 Adana, Turkey
[2] Cukurova Univ, Fac Med, Dept Histol, Div Neurophysiol, TR-01330 Adana, Turkey
[3] Cukurova Univ, Fac Med, Dept Anaesthesiol, Div Neurophysiol, TR-01330 Adana, Turkey
关键词
ketamine; median raphe nucleus; 5-HT; (5-hydroxytryptamine; serotonin); anxiety; fear; memory;
D O I
10.1016/S0014-2999(01)01340-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present study was to determine the involvement of the median raphe serotonergic system in the effects of ketamine on anxiety behaviours, and related memory. The effects of ketamine pretreatment (3 and 10 mg/kg, i.p.) on three types of fear-motivated behaviours, unconditioned one-way escape, conditioned avoidance and freezing were tested. Experiments were performed with the inhibitory avoidance apparatus in rats with ibotenic acid lesions of the median raphe nucleus. It was found that 10 mg/kg ketamine had an anxiogenic-like effect on one-way escape type of fear and anxiolytic-like effect on conditioned freezing-related fear; these effects were unaffected by median raphe lesions, Both ketamine doses impaired freezing-related fear memory. Ketamine (10 mg/kg) also produced an anxiolytic-like effect on avoidance type of fear and impaired avoidance memory. The median raphe lesions attenuated the anxiolytic action of the drug on the avoidance type of fear and prevented ketamine-induced avoidance memory impairment. These results suggest that the anxiolytic-like effect of ketamine on avoidance-type fear is mediated through the median raphe serotonergic system. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:315 / 320
页数:6
相关论文
共 54 条
[41]  
Silvestre J S, 1997, Depress Anxiety, V5, P29, DOI 10.1002/(SICI)1520-6394(1997)5:1<29::AID-DA5>3.0.CO
[42]  
2-0
[43]   PROPERTIES OF THE OPTICAL ISOMERS AND METABOLITES OF KETAMINE ON THE HIGH-AFFINITY TRANSPORT AND CATABOLISM OF MONOAMINES [J].
SMITH, DJ ;
AZZARO, AJ ;
ZALDIVAR, SB ;
PALMER, S ;
LEE, HS .
NEUROPHARMACOLOGY, 1981, 20 (04) :391-396
[44]   BEHAVIORAL-EFFECTS OF SELECTIVE MIDBRAIN RAPHE LESIONS IN RAT [J].
SREBRO, B ;
LORENS, SA .
BRAIN RESEARCH, 1975, 89 (02) :303-325
[45]   Effects of the 5-HT3 receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice [J].
Suzuki, T ;
Aoki, T ;
Kato, H ;
Yamazaki, M ;
Misawa, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 385 (2-3) :99-102
[46]   THE RAPHE NUCLEI OF THE BRAIN STEM IN THE CAT .1. NORMAL TOPOGRAPHY AND CYTOARCHITECTURE AND GENERAL DISCUSSION [J].
TABER, E ;
BRODAL, A ;
WALBERG, F .
JOURNAL OF COMPARATIVE NEUROLOGY, 1960, 114 (02) :161-&
[47]   AN N-METHYLASPARTATE RECEPTOR-MEDIATED SYNAPSE IN RAT CEREBRAL-CORTEX - A SITE OF ACTION OF KETAMINE [J].
THOMSON, AM ;
WEST, DC ;
LODGE, D .
NATURE, 1985, 313 (6002) :479-481
[48]   Systemic EMD 68843 injections reduce anxiety in the shock-probe, but not the plus-maze test [J].
Treit, D ;
Degroot, A ;
Kashluba, S ;
Bartoszyk, GD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 414 (2-3) :245-248
[49]   THE DISRUPTIVE EFFECTS OF KETAMINE ON PASSIVE-AVOIDANCE LEARNING IN MICE - INVOLVEMENT OF DOPAMINERGIC MECHANISM [J].
UCHIHASHI, Y ;
KURIBARA, H ;
ISA, Y ;
MORITA, T ;
SATO, T .
PSYCHOPHARMACOLOGY, 1994, 116 (01) :40-44
[50]   Fluvoxamine for the treatment of anxiety disorders in children and adolescents [J].
Walkup, JT ;
Labellarte, MJ ;
Riddle, MA ;
Pine, DS ;
Greenhill, L ;
Klein, R ;
Davies, M ;
Sweeney, M ;
Abikoff, H ;
Hack, S ;
Klee, B ;
McCracken, J ;
Bergman, L ;
Piacentini, J ;
March, J ;
Compton, S ;
Robinson, J ;
O'Hara, T ;
Baker, S ;
Vitiello, B ;
Ritz, LA ;
Roper, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (17) :1279-1285